Company news
Dyne Therapeutics, Inc. news in 2023
Dyne Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.
Dyne Therapeutics to Present at November Investor Conferences
November 6, 2023
Dyne Therapeutics Reports Third Quarter 2023 Financial Results and Provides Update on Significant Progress for ACHIEVE and DELIVER Trials and Upcoming Clinical Milestones
October 29, 2023
Dyne Therapeutics to Present at October Investor Conferences
September 27, 2023
Dyne Therapeutics Receives FDA Orphan Drug Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1
September 19, 2023
Dyne Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
September 4, 2023
Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
August 2, 2023
Dyne Therapeutics to Present at Jefferies Healthcare Conference
May 31, 2023
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-101
May 24, 2023
Dyne Therapeutics’ Preclinical Data Demonstrating FORCE™ Platform Delivery to CNS Featured in Oral Presentation at ASGCT Annual Meeting
May 16, 2023
Dyne Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
May 10, 2023
Dyne Therapeutics to Present at BofA Securities 2023 Healthcare Conference
May 2, 2023
Dyne Therapeutics to Present New Preclinical Data at ASGCT Annual Meeting Demonstrating FORCE™ Platform Delivery to CNS
May 1, 2023
Dyne Therapeutics Receives FDA Orphan Drug and Rare Pediatric Designations for DYNE-251 for the Treatment of Duchenne Muscular Dystrophy
March 22, 2023
Dyne Therapeutics Announces Presentations on its DM1 and DMD Programs at the 2023 Muscular Dystrophy Association Clinical & Scientific Conference
March 19, 2023
Dyne Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
March 1, 2023
Dyne Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
January 2, 2023
Decks in 2023
- AAN Annual Meeting 2023
Conference · 8 slides · Apr 25, 2023